Navigation Links
Rejection Rate for Liver Transplants Patient Reduced

The dawn of the New Year has brought with it a new lease of life for Organ transplant patients who have liver failure. For these //patients the uphill struggle doesn’t stop with finding a matching donor. In fact it would have just started.

Research has shown that despite all high tech matching done for liver transplant patients, organ rejection is still a common phenomenon. Transplant surgeon Ignazio Marino, M.D., of Thomas Jefferson University Hospital in Philadelphia, says that rejection happens in at least 40 percent of patients undergoing a liver transplant. A new medical breakthrough has shown that the combination of certain drugs has been able to reduce the chances of rejection among liver transplant.

Dr. Marino and a team of researchers studied the effect of two anti-rejection drugs, Basiliximab and Tacrolimus. The medications were given to 50 liver transplant patients over a course of time.

"These two drugs, used in combination, allowed us to have a significant decrease in the rejection," Dr. Marino announced. "We went from about 40 percent rejection to only 12 percent."

Dr. Marino says this treatment is a sign of good things to come. "A transplant is not any longer a treatment to save a life momentarily. It is a treatment to give an excellent quality of life back to our patients."

Both drugs have been FDA approved and have minimal side affects.


'"/>




Page: 1

Related medicine news :

1. A Urine Test Could Predict Rejection In Transplant Patients
2. Peer Rejection Leads To Reduced Participation In Classroom Activities
3. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
4. Low Dose Anti Rejection Protocol Helps Intestinal Transplant Recipients
5. Survey Reveals Rejection of NHS Database Scheme
6. Ontario Supports OHIP’s Rejection of Claim by North York Ma
7. Stem Cell Finding Could Help Reduce Transplant Rejection
8. Blood Cells Capable of Regenerating Liver
9. Liver donors can thrive after transplant
10. Heavy Drinking Raises Risk of Liver Cancer
11. Arthritis Drug May Cause Liver Damage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... 2017 , ... Elisabete Miranda, president and CEO of ... magazine as one of its 2017 Enterprising Women of the Year, a prestigious ... that they have fast-growth businesses, mentor or actively support other women and girls ...
(Date:4/26/2017)... NJ (PRWEB) , ... April 26, 2017 , ... RawTrition ... an easy way to get nutrients from SUPERFOODS! , RawTrition is taking ... at the cellular level because the body recognizes its raw form (unlike the synthetically ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, ... to announce that it has received 510(k) clearance from the U.S. Food & ... the MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: